Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Ending Cash Position : ¥685 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Bio-Sincerity Pharma-Tech Co Ending Cash Position?

Hangzhou Bio-Sincerity Pharma-Tech Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥685 Mil.

Hangzhou Bio-Sincerity Pharma-Tech Co's quarterly Ending Cash Position declined from Sep. 2023 (¥830 Mil) to Dec. 2023 (¥778 Mil) and declined from Dec. 2023 (¥778 Mil) to Mar. 2024 (¥685 Mil).

Hangzhou Bio-Sincerity Pharma-Tech Co's annual Ending Cash Position declined from Dec. 2021 (¥2,009 Mil) to Dec. 2022 (¥1,211 Mil) and declined from Dec. 2022 (¥1,211 Mil) to Dec. 2023 (¥778 Mil).

Hangzhou Bio-Sincerity Pharma-Tech Co Ending Cash Position Historical Data

The historical data trend for Hangzhou Bio-Sincerity Pharma-Tech Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Bio-Sincerity Pharma-Tech Co Ending Cash Position Chart

Hangzhou Bio-Sincerity Pharma-Tech Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

188.82

132.61

2,009.00

1,211.07

778.45

Hangzhou Bio-Sincerity Pharma-Tech Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,245.71	1,016.83	829.69	778.45	684.65

Hangzhou Bio-Sincerity Pharma-Tech Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hangzhou Bio-Sincerity Pharma-Tech Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1211.068	+	-432.615
	=	778

Hangzhou Bio-Sincerity Pharma-Tech Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	778.453	+	-93.803
	=	685

Hangzhou Bio-Sincerity Pharma-Tech Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hangzhou Bio-Sincerity Pharma-Tech Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Bio-Sincerity Pharma-Tech Co Ltd (SZSE:301096) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

611 Dongguan Road, 2nd Floor, Building 8, Jinsheng Technology Park, Binjiang District, Hangzhou, CHN

Website

https://www.hzbio-s.com

Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is a pharmaceutical technology research and development company. The company's business covers drug discovery, pharmaceutical research, clinical research, and registration application.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Headlines

No Headlines